Texas A&M Football

Momentum Shifts: Offense leads A&M to victory in Fayetteville

Behind a wonderful performance by Marcel Reed, Texas A&M rode its offense to a high-scoring battle at a soggy Donald W. Reynolds Razorback Stadium in Week 8. Now 7-0 for the first time since 1994, the Aggies control their own destiny with five regular-season games remaining.
By Max Wright
October 21, 2025
2.3k Views
Discuss
Story Poster
Photo by Jamie Maury, TexAgs

On the road in Fayetteville, the Aggies found themselves in a high-scoring battle with one of the most efficient offenses in the country. Arkansas came into this matchup with the top-ranked offense in college football, and the Hogs proved why. The Razorbacks moved the ball consistently and piled up over 500 yards of total offense.

But when it mattered most, Texas A&M’s offense answered the call again and again.

To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Collin Klein Mike Elko Holmon Wiggins Momentum Shifts Taylen Green Texas A&M at Arkansas EJ Smith Amari Daniels Rueben Owens II Le'Veon Moss Marcel Reed KC Concepcion
Show All
Mario Craver Ashton Bethel-Roman Jamarion Morrow Football Texas A&M Arkansas 2025
SPONSORED BY
American Momentum Bank
More Football
See All →
Charean Williams discusses lessons learned from A&M's win at Arkansas
By David Nuño
Presenting Texas Aggies United’s Final SEC Showdown at Kyle Sweepstakes!
By Texas Aggies United
Offensive keys to beating LSU as the Aggies round into form
By Jake Hubenak
Offense in Review feat. Stephen McGee: Texas A&M 45, Arkansas 42
By Billy Liucci
Discussion from...

Momentum Shifts: Offense leads A&M to victory in Fayetteville

1,987 Views | 0 Replies | Last: 2 hrs ago by Max Wright
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.